Josh Wolfe

Director

Josh Wolfe (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Eikon Therapeutics, Inc. (EIKN). Across 2 priced purchase filings, the average 21-session return was -15.7% from execution and -2.0% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of EIKN (277,776 sh across 2 lots, as filed), executed Feb 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-15.7%

avg across 2 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-2.0%

same 2 filings, from disclosure

Filings, ttm

2 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$10.0M

shares × price, as filed

Last traded

Feb 4

Filed Feb 6

Median ADV $4.4M across their filed names

Open performance→

Volume by month

Buys $10.0M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

EIKN

Eikon Therapeutics, Inc. EIKN · 2 buys · 0 sells 2 filings

Recent filings

EIKNPURCHASE Eikon Therapeutics, Inc. View filing → $5.0M
277,776 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 6:27 PM ET EIKNPURCHASE Eikon Therapeutics, Inc. View filing → $5.0M
277,776 sh across 2 lots
Exec Feb 4
Filed Feb 6 · 6:25 PM ET